GENERAL, O. Reg. 256/24

Section 55

Piercing dermis

Cite as GENERAL, O. Reg. 256/24, s. 55 · current to November 11, 2026 · consolidated from September 30, 2026 · read from e-Laws on November 16, 2026

The text

(1) For the purposes of paragraph 5 of subsection 4 (1) of the Act, a member referred to in subsection (2) of this section who meets all the requirements of subsection (4) is authorized to perform the act of piercing a patient’s dermis with a lancet-type device to obtain blood. (2) A Part A pharmacist, an intern, a Part A pharmacy technician and an intern technician are authorized to perform the act provided for in subsection (1), subject to the terms, conditions and limitations imposed on their certificate of registration. (3) A Part A pharmacy technician and an intern technician shall not perform the act provided for in subsection (1) unless, (a) a Part A pharmacist is physically present on the premises at the time the act is performed; (b) they are under the direction of a Part A pharmacist at the time the act is performed; and (c) if the act is performed to administer a point-of-care test, a Part A pharmacist interprets the results of the test and makes any professional decision arising from those results. (4) A member may only perform the act provided for in subsection (1) if the member complies with the following: 1. The member may only perform the act for the purpose of demonstrating the appropriate use of lancet-type devices for the patient’s self-care and education or for the patient’s self-monitoring of their chronic disease, unless the act is performed to administer a point-of-care test. 2. The member may only perform the act to administer a point-of-care test if the test is listed in subsection 28 (2) of Ontario Regulation 45/22 (General) made under the Laboratory and Specimen Collection Centre Licensing Act and if it is administered for the purpose of assisting patients with the management of their medication to treat chronic disease. 3. Before performing an act described in paragraphs 1 or 2 the member must, i. explain the purpose to the patient or their authorized agent, and ii. receive an informed consent from the patient or their authorized agent. 4. The member shall ensure that the member only performs the act in an environment that is clean, safe, private and comfortable for the patient. 5. The member shall ensure that appropriate infection control procedures are in place. 6. The member must possess the knowledge, skill and judgment respecting the performance of the act and understand the condition of the patient, to perform it safely and effectively. 7. The member must consider whether performing the act on the patient is appropriate, given the known risks and benefits to the patient and the safeguards and resources available to safely manage the outcome and any other relevant circumstances. 8. The member must maintain a patient record that includes, i. the name and address of the patient, ii. the name and work address of the member, iii. the date the act was performed, iv. the circumstances relating to the performance of the act and any adverse reaction experienced by the patient, v. confirmation that an informed consent was given by the patient or their agent, and vi. if the act was performed to administer a point-of-care test, A. the results of the test, and B. the professional decision arising from the results of the test and the rationale for the decision. 9. If the act is performed to administer a point-of-care test, the member must notify the patient’s primary care provider, if any, within a reasonable time that the member performed the act and provide details respecting the act.
Read the GENERAL on e-Laws ↗

Made under Pharmacy Act, 1991, S.O. 1991, c. 36.